University of Mississippi Medical Center
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of Mississippi Medical Center sits in the top decile of US sponsors by registered trial count (#245 of 15,742 sponsors by registered trial count).
University of Mississippi Medical Center: 96 sponsored US clinical trials, 10 recruiting.
University of Mississippi Medical Center sponsors 96 registered US clinical trials on ClinicalTrials.gov, 10 of them currently recruiting, and 65 completed. 10 of these trials are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Sedentary Behavior, with 2 trials.
Top-decile sponsor footprint
University of Mississippi Medical Center ranks in the top decile of sponsors by registered trial count (#245 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
65 of 79 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
96 total, page 1 of 2
Evaluation of Home-based Telerehabilitation Platform to Augment Orthopedic Rehabilitation
NCT06973642
Mississippi Community Engagement Alliance (MS CEAL): Fostering Community Solutions
NCT07071064
Teen Mom Study Feasibility Trial
NCT05843903
Neuromodulation to Reduce Muscle Stiffness Following Spinal Cord Injury
NCT06274021
Empagliflozin in ESKD - A Feasibility Study
NCT05687058
Low Systemic/High Local Exercise Load in Peds SCD
NCT06387758
Transcutaneous Spinal Stimulation for Lower Limb Spasticity in Spinal Cord Injury
NCT05457205
The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity
NCT07052539
Transpulmonary Pressure Guided Mechanical Ventilation Weaning in Obesity
NCT05530434
Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia
NCT02989025
Community Interventions to Improve Breastfeeding
NCT05503069
Evaluation of a Telehealth DPP With Medicare Patients at the University of Mississippi Medical Center
NCT04822480
Pomegranate Supplementation and Well-Being Among Medical Students and Residents
NCT03063372
Low Dose Bolus Ketamine For Use In Sickle Cell Pain Crisis
NCT07682662
Evaluation of Endobronchial Ultrasound Needle Cleaning Techniques and Their Impact on Specimen Contamination
NCT07461662
Weight Bearing After Pelvis and Acetabulum Fracture Fixation
NCT07189156
Pharmacokinetics of Essential Oils in Different Capsules
NCT07581522
Mississippi Violence Injury Prevention (VIP) Program
NCT06736730
The Effects of Palmar Cooling on Repeated Sprinting Ability
NCT06356142
Identification of Surrogate Blood and/or Urine Biomarker for Immulina TM (Trademark) in Normal Humans
NCT05556967
Virtual Reality as an Adjuvant Therapy for Sickle Cell Vaso-Occlusive Crisis in the Pediatric Emergency Department
NCT05864092
Effects of Immulina TM Supplements With PASC Patients
NCT05524532
Spirulina Oral Supplement for Enhancing Host Resilience to Virus Infection
NCT05447078
Effect of GLP-1 Receptor Agonists on Trabecular Bone Score
NCT04964388
Visual Feedback Monitoring During Exercise in Individuals With Obesity
NCT04685707
Vascular Dysfunction in Black Individuals: Roles of Nitric Oxide and Endothelin-1
NCT04770155
#BabyLetsMove Physical Activity Feasibility Trial
NCT04628065
Obesity in Pediatric Sickle Cell Disease: A New Phenomenon
NCT04676113
STAMPP-HTN in a High-risk Rural Population of Women
NCT04570124
Telehealth Diabetes Prevention Intervention for African American Youth
NCT04618458
Minimizing Pathologic Aspiration in Patients Undergoing Esophageal and Lung Resections for Cancer
NCT04251312
Effects of Immulina on Immune Measures
NCT04071730
Sensorimotor Training for Injury Prevention in Collegiate Soccer Players II
NCT04036916
Remote Patient Monitoring in Pediatric Obesity
NCT04029597
Balance Bike Training in Down Syndrome
NCT03677245
Hypertension Management Using Telemonitoring
NCT03700775
Training for Injury Prevention in Collegiate Soccer Players
NCT03594669
Non-invasive Tidal Volume Monitoring Using the Linshom Respiratory Monitoring Device
NCT03279458
Diagnostic Efficiency of Touch Imprints Versus Smears
NCT03224910
Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema Patients
NCT02713035
Wellness and Weight Family Group Project
NCT02677792
A Phase 1 Study of Continuous Intravenous L-citrulline During Sickle Cell Pain Crisis or Acute Chest Syndrome
NCT02697240
Evaluation of Abdominal Wall Thickness at Possible Trocar Sites Based on Body Mass Index
NCT02712216
Endotracheal Tube Audible Leak Test
NCT02461017
Brief Behavioral Activation Intervention for Depressed Asthma and Urticaria Patients
NCT02382562
Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study
NCT02315248
Intranasal Dexmedetomidine Premedication in Children
NCT02250703
Peripheral Nerve Blocks in Pediatric Orthopedic Patients
NCT02236130
Examining the Effectiveness of Self-Acceptance Group Therapy
NCT02121561
Hysteroscopic Assessment of Fallopian Tubal Patency
NCT02005263
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 5 |
| Phase 3 | 5 |
| Phase 4 | 5 |
Therapeutic Areas
What is open in the University of Mississippi Medical Center pipeline
10 recruiting of 96 indexed (10% open); 65 completed (68%).
Phase mix: 10 late (III/IV) vs 10 early (I/II) (balanced across stages).
Top condition: Sedentary Behavior (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Mississippi Medical Center: open-pipeline peers nationwide
Peers matched on 96 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
University of Mississippi Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 96 trials (± recruiting share)
- Masimo Corporation · 96 trials · 3% recruiting
- University of Tennessee · 96 trials · 13% recruiting
- Arkansas Children's Hospital Research Institute · 97 trials · 19% recruiting
- AdventHealth · 95 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Zimmer Biomet · 10% recruiting · 115 trials
- SWOG Cancer Research Network · 10% recruiting · 270 trials
- Vertex Pharmaceuticals Incorporated · 10% recruiting · 191 trials
- California Pacific Medical Center Research Institute · 10% recruiting · 29 trials
Related
What to do with this University of Mississippi Medical Center page
96 registered trials is a research-attention snapshot, not an endorsement of University of Mississippi Medical Center or any single study.
- 10 of University of Mississippi Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Sedentary Behavior is the condition University of Mississippi Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Sedentary Behavior trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Mississippi Medical Center pipeline card: 96 registered trials from official public datasets.Report a data error.